At present, many studies have not yet perfected the exploration of the pathogenesis of SGK1's involvement in MDD, and there are many conflicting conclusions, such as whether the above electroconvulsive therapy is effective for MDD recovery, and whether SGK1 is elevated or decreased in MDD patients. The gene discussed is SGK1; the disease is major depressive disorder.